KRONOS BIO INC

KRON05 Dec 2024
Healthcare
$0.92
+0.05 (+4.51%)
Lowest Today
$0.9
Highest Today
$0.95
Today’s Open
$0.92
Prev. Close
$0.9
52 Week High
$1.6
52 Week Low
$0.69
To Invest in KRONOS BIO INC

KRONOS BIO INC

Healthcare
KRON05 Dec 2024
+0.05 (+4.51%)
1M
3M
6M
1Y
5Y
Low
$0.9
Day’s Range
High
$0.95
0.9
52 Week Low
$0.69
52-Week Range
52 Week High
$1.6
0.69
1 Day
-
1 Week
-6.45%
1 month return
-5.21%
3 month return
-8.16%
6 month return
+21.78%
1 Year return
-25%
3 Years return
-92.59%
5 Years return
-
10 Years return
-
Institutional Holdings
Vida Ventures Advisors, LLC
4.58
Millennium Management LLC
3.39
Vanguard Group Inc
3.19
PARTNERS CAPITAL INVESTMENT GROUP, LLP
2.67
Alphabet Inc
2.38
Vanguard Total Stock Mkt Idx Inv
2.19
Wildcat Capital Management, LLC
2.15

Market Status

Fundamentals
Market Cap
58.75 mln
PB Ratio
0.53
PE Ratio
0
Enterprise Value
-40.31 mln
Total Assets
213.28 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. The company was incorporated in 2017 and is headquartered in San Mateo, California.
Organisation
KRONOS BIO INC
Employees
58
Industry
Biotechnology
CEO
Dr. Norbert W. Bischofberger Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities